Nature Structural & Molecular Biology
Nature Structural & Molecular Biology (commonly abbreviated as Nat. Struct. Mol. Biol.) is the structural and molecular biology title in the Nature Portfolio. The current name dates from January 2004, succeeding Nature Structural Biology founded in 1994, and as a monthly it reports a 2025 impact factor of 10.1.Nature Structural & Molecular Biology(常用缩写 Nat. Struct. Mol. Biol.)是 Nature Portfolio 的结构与分子生物学期刊,现刊名始于 2004 年 1 月,前身为 1994 年创刊的 Nature Structural Biology,为月刊,2025 年影响因子为 10.1。[1]
Scope
- Scope: an integrated forum reflecting the growing integration of structural and molecular studies, placing a strong emphasis on understanding the molecular mechanisms underlying biological processes.学科定位: 反映结构研究与分子研究日益融合的综合论坛,重在理解生物过程的分子机制。[2]
- Topics: DNA replication, repair and recombination, chromatin structure and remodelling, transcription, translation, folding, processing, transport and degradation of proteins and RNA, and signal transduction and membrane processes.收录主题: DNA 复制、修复与重组,染色质结构与重塑,转录,翻译,蛋白质与 RNA 的折叠、加工、转运与降解,信号转导与膜过程。
- Article types: research articles, reviews, and news and commentary.文章体裁: 研究论文、综述、新闻与评论。
- Publishing model: hybrid, with subscription and open access routes side by side.出版模式: 混合出版,订阅路线与开放获取选项并行。
- Indexing and metrics: covered by the SCIE, Scopus and Medline, with a 2025 impact factor of 10.1.收录与指标: 被 SCIE、Scopus 与 Medline 收录,2025 年影响因子 10.1。
History
- Predecessor: the predecessor Nature Structural Biology was launched in New York in January 1994.前身创刊: 前身 Nature Structural Biology 于 1994 年 1 月在纽约创刊。[3]
- Renaming: the current title was adopted in January 2004 with continuous volume numbering, the ISSNs changing from 1072-8368 to 1545-9993 and 1545-9985.更名: 2004 年 1 月改用现名,卷期接续,ISSN 由 1072-8368 变更为 1545-9993 与 1545-9985。[4]
- Publisher: published by Nature Portfolio within Springer Nature, with the editorial office in London.出版方: 现由 Springer Nature 旗下的 Nature Portfolio 出版,编辑部设于伦敦。
- Editorial transition: Carolina Perdigoto joined the journal as chief editor in May 2021.主编更替: Carolina Perdigoto 于 2021 年 5 月加入本刊任主编。
Editors
- Editor-in-chief: Carolina Perdigoto, a PhD from the Institut Pasteur, working on transcriptional regulation and epidermal development.现任主编: Carolina Perdigoto,巴斯德研究所博士,研究方向为转录调控与表皮发育。
- Other editors: senior editors Katarzyna Ciazynska, Sara Osman and Dimitris Typas, plus consulting senior editor Eytan Zlotorynski.其他编辑: 高级编辑 Katarzyna Ciazynska、Sara Osman 与 Dimitris Typas,另设咨询资深编辑 Eytan Zlotorynski。
- Editorial board: no external editorial board, decisions rest with a full-time editing team spread across London, Berlin and Milan.编委构成: 不设外部编委会,编辑决策由分驻伦敦、柏林与米兰的全职编辑团队作出。
- Submission and review: submissions go through the online manuscript tracking system under single-anonymized review by default, with an optional double-anonymized route and presubmission enquiries accepted.投稿与评审: 经在线稿件追踪系统投稿,默认单盲评审,可选双匿名评审,接受投稿前咨询。[5]